These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7273580)

  • 1. Eosinophilia associated with cholestyramine.
    Parker PH; Ghishan FK; Shanks D; Greene HL
    Clin Pediatr (Phila); 1981 Oct; 20(10):675-6. PubMed ID: 7273580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of cholestyramine in the treatment of refractory diarrhea in infants and the newborn].
    Blanckaert D; Farriaux JP
    Nouv Presse Med; 1976 Mar; 5(11):713-4. PubMed ID: 772596
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholestyramine therapy for intractable diarrhea.
    Tamer MA; Santora TR; Sandberg DH
    Pediatrics; 1974 Feb; 53(2):217-20. PubMed ID: 4812005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholestyramine in hepatology].
    Hecht Y
    Med Chir Dig; 1978; 7(8):705-8. PubMed ID: 570624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum-lipid reducing principles--possibilities for treatment. 7. Ion exchangers (cholestyramine)].
    Nikkilä EA
    Lakartidningen; 1970 Dec; 67():Suppl IV:83+. PubMed ID: 5511955
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypercholesterinemia: treatment with Colestyramin].
    Weizel A
    Fortschr Med; 1972 Jun; 90(18):715-8. PubMed ID: 5082079
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Cholestyramine therapy for intractable diarrhea.
    Dehghanian J
    Pediatrics; 1974 Oct; 54(4):516. PubMed ID: 4414144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fecal excretion of bile acids in infantile diarrhea syndrome according to its developmental form].
    Emilfork Soto M; Duffau Toro G; Bascur DL; Urbina AM
    Bol Med Hosp Infant Mex; 1982 Mar; 39(3):177-80. PubMed ID: 6807329
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects of cholestyramine and aluminium hydroxide on the biliary bile acid excretion in rats. An experimental model for the depletion of bile acids in bile.
    Gregus Z; Barth A; Fischer E; Zaumseil J; Klinger W; Varga F
    Acta Biol Med Ger; 1980; 39(6):705-9. PubMed ID: 7456933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile Acid Sequestrants Are Contraindicated for Patients With Hypertrigly-ceridemia: A Case Report.
    Malecki EA
    Am J Gastroenterol; 2021 Jun; 116(6):1352. PubMed ID: 33491957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged diarrhea in infancy: effect of deconjugated bile acids and cholestyramine action].
    Heffes LA; Litwin NH; Licastro R; Cervetto JL
    Acta Gastroenterol Latinoam; 1980; 10(1):49-56. PubMed ID: 7435128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relief of pruritus by cholestyramine in chronic liver disease.
    Oster ZH; Rachmilewitz EA; Moran E; Stein Y
    Isr J Med Sci; 1965 Jul; 1(4):599-606. PubMed ID: 5842274
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-enteropathy and bile acid malabsorption: response to cholestyramine.
    Steuerwald M; Bucher HC; Müller-Brand J; Götze M; Roser HW; Gyr K
    Am J Gastroenterol; 1995 Nov; 90(11):2051-3. PubMed ID: 7485023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the in vitro binding of D-penicillamine to cholestyramine.
    Allgayer H; Kruis W; Paumgartner G
    Experientia; 1982 Apr; 38(4):482-4. PubMed ID: 7084416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal obstruction associated with cholestyramine therapy.
    Merten DF; Grossman H
    AJR Am J Roentgenol; 1980 Apr; 134(4):827-8. PubMed ID: 6767374
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypernatremia associated with cholestyramine therapy.
    Primak WA; Gartner LM; McGurk HE; Spitzer A
    J Pediatr; 1977 Jun; 90(6):1024-5. PubMed ID: 859053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perspectives of conservative treatment and prevention of cholelithiasis].
    Keclík M
    Cesk Gastroenterol Vyz; 1973 Apr; 27(3):177-81. PubMed ID: 4702023
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Hyperchloremia, metabolic acidosis, and cholestyramine.
    Hartline JV
    J Pediatr; 1976 Jul; 89(1):155. PubMed ID: 932886
    [No Abstract]   [Full Text] [Related]  

  • 19. Intestinal obstruction associated with cholestyramine therapy.
    Cohen MI; Winslow PR; Boley SJ
    N Engl J Med; 1969 Jun; 280(23):1285-6. PubMed ID: 5770053
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased biliary excretion of tributylmethyl ammonium in cholestyramine pretreated rats due to reduced formation of ion-pair complexes with hepatic bile salts.
    Choi MK; Song IS; Kim DD; Chung SJ; Shim CK
    Biopharm Drug Dispos; 2007 Dec; 28(9):485-90. PubMed ID: 17955510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.